Endeavor BioMedicines
Clinical-stage biotechnology company targeting the core drivers of terminal diseases including oncology and fibrosis. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€482—723m (Dealroom.co estimates Apr 2024.)
San Diego California (HQ)
Authorizing premium user...